Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study

被引：0
|
作者：
Christopher F. Bell
Jake Chung
Bernard Rubin
机构：
[1] GSK,US Value Evidence and Outcomes
[2] GSK,Specialty Care, Global Medical Affairs
[3] GSK,US Medical Affairs, Immuno
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
African American ethnicity; Belimumab; Hispanic ethnicity; Real-world data; Systemic lupus erythematosus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 462
页数：15
相关论文
共 50 条
  • [21] Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
    Johannes, von Kempis
    Sabine, Duetsch
    Nicola, Reuschling
    Rahel, Villiger
    Peter, Villiger M.
    Florencee, Vallelian
    Dominik, Schaer J.
    Ruediger, Mueller B.
    SWISS MEDICAL WEEKLY, 2019, 149
  • [22] Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence
    Gomez, Alvaro
    Enman, Yvonne
    Parodis, Ioannis
    PATIENT-RELATED OUTCOME MEASURES, 2023, 14 : 1 - 13
  • [23] Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
    Bell, Christopher F.
    Priest, Julie
    Stott-Miller, Marni
    Kan, Hong
    Amelio, Justyna
    Song, Xue
    Limone, Brendan
    Noxon, Virginia
    Costenbader, Karen H.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [24] FACTORS ASSOCIATED WITH GLUCOCORTICOID-FREE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH BELIMUMAB IN THE REAL-WORLD SETTINGS: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY IN JAPAN
    Yamane, T.
    Hashiramoto, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1461 - 1461
  • [25] Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study
    Sun, Fangfang
    Wu, Huaxiang
    Wang, Zitao
    Wu, Tong
    Wu, Xue
    Chen, Jie
    Zhang, Danting
    Bao, Chunde
    Shen, Nan
    Wu, Lijun
    Zhu, Jing
    Ye, Shuang
    BIOMEDICINES, 2023, 11 (03)
  • [26] Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
    Tan, Meng
    Xu, Jing
    Tan, Ying
    Qu, Zhen
    Yu, Feng
    Zhao, Minghui
    KIDNEY DISEASES, 2023, 9 (03) : 218 - 228
  • [27] Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
    Jin, Hui-Zhi
    Li, Yu-jing
    Wang, Xin
    Li, Zhijun
    Ma, Bin
    Niu, Lin
    Wang, Peng
    Pan, Hai-feng
    Li, Si-dong
    Bao, Wei
    Wang, Guosheng
    Li, Xiao-mei
    Chen, Zhu
    LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
  • [28] Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab
    Wei, Si-Ru
    Zhu, Zhen-Zhen
    Xu, Jia
    Mo, Han-You
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 154 - 156
  • [29] BELIMUMAB FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL WORLD: A SINGLE CENTER STUDY
    Fragio Gil, J. J.
    Martinez Calabuig, P.
    Salvador Maicas, L.
    Gonzalez Mazario, R.
    Rueda, A.
    Lerma, J. J.
    Molina Almela, C.
    Pastor Cubillo, M. D.
    Campos Fernandez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1478 - 1478
  • [30] Belimumab-Treated Patients with Systemic Lupus Erythematosus Without Prior Immunosuppressant Use Have More Favorable Clinical Outcomes Than Those with Prior Use of an Immunosuppressant
    DerSarkissian, Maral
    Chen, Yan
    Rabideau, Brendan
    Man, Theo
    Worley, Karen
    Rubin, Bernard
    Costenbader, Karen
    Lim, S. Sam
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3125 - 3127
12345